PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15307162-5	2004	The presence of the PL shell enveloping a PLG core essentially eliminated the initial "burst" of piroxicam that was observed when the drug was released from pure PLG microspheres.	Piroxicam	97-106	plasminogen	Homo sapiens	42-45	
16052542-3	2005	The effect of shell thickness on release of a model drug, piroxicam, has been clearly shown for 2- to 15-microm thick shells of poly(D,L-lactide) (PDLL) surrounding a poly(D,L-lactide-co-glycolide) (PLG) core and compared to pure PLG microspheres loaded with piroxicam.	Piroxicam	58-67	plasminogen	Homo sapiens	199-202	
16052542-3	2005	The effect of shell thickness on release of a model drug, piroxicam, has been clearly shown for 2- to 15-microm thick shells of poly(D,L-lactide) (PDLL) surrounding a poly(D,L-lactide-co-glycolide) (PLG) core and compared to pure PLG microspheres loaded with piroxicam.	Piroxicam	58-67	plasminogen	Homo sapiens	230-233	
15773062-3	2005	In this study, a model is developed to independently determine the contributions of each of these factors by fitting the release of piroxicam from monodisperse 50-microm microspheres made with PLG of different initial molecular weights.	Piroxicam	132-141	plasminogen	Homo sapiens	193-196	
15307162-5	2004	The presence of the PL shell enveloping a PLG core essentially eliminated the initial "burst" of piroxicam that was observed when the drug was released from pure PLG microspheres.	Piroxicam	97-106	plasminogen	Homo sapiens	162-165	
12880292-9	2003	Rhodamine partitioned to the surface and piroxicam partitioned to the interior of large PLG microspheres.	Piroxicam	41-50	plasminogen	Homo sapiens	88-91